Biotech

All Articles

Lilly, Haya ink $1B biobuck being overweight deal to search black genome

.Eli Lilly's hunt for obesity aim ats has actually led it to the darker genome. The Big Pharma has a...

ArsenalBio increases $325M, turns away from former lead asset

.Arsenal Biosciences is actually going on up. The tissue treatment provider has actually added $325 ...

Lilly- backed fat burning biotech documents IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has actually f...

Aelis' marijuana make use of medicine fails stage 2b, driving Indivior to re-think $100M possibility

.Aelis Farma's chances of safeguarding a fast, favorable choice on a $one hundred thousand possibili...

ProKidney stops phase 3 test certainly not needed for tissue therapy authorization

.ProKidney has actually quit one of a set of period 3 tests for its own cell treatment for kidney di...

Vaxcyte surges on 'stunning' 31-valent PCV succeed against Pfizer

.Vaxcyte introduced what professionals named "impressive" phase 1/2 records for its 31-valent pneumo...

Recursion's mind disease trial shows scant evidence of efficacy

.Recursion has actually discovered by means of a very early test of its own tech-enabled approach to...

Acepodia, Pfizer click on with each other for chemistry-based tissue treatment

.Call it an instance of great chemical make up: Acepodia, a biotech based on Nobel Prize-winning sci...

Praxis epilepsy drug lessens confiscations in stage 2 hearing

.Practice Precision Medicines has scored an additional midphase gain in epilepsy this year, with its...

Three execs resign as Dyne articles mixed data for DMD applicant

.After getting away from a professional hold several years back, Dyne Rehab has disclosed brand-new ...